KATHRYN E FALBERG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KATHRYN E FALBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is a Director in HUMAN GENOME SCIENCES INC ($HGSI) and a Director in MEDIVATION, INC. ($MDVN) and a Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a Director in aTYR PHARMA INC ($LIFE) and a in Tricida, Inc. ($TCDA) and a Director in Tricida, Inc. ($TCDA) and a Director in Aimmune Therapeutics, Inc. ($AIMT) and a Director in Axovant Sciences Ltd. ($AXON) and a Director in Trade Desk, Inc. ($TTD) and a Director in UroGen Pharma Ltd. ($URGN) and a Director in Arcus Biosciences, Inc. ($RCUS) and a Director in Nuvation Bio Inc. ($PANA).
Address: 14200 SHADY GROVE ROAD ROCKVILLE 20850 MD
Companies in which KATHRYN E FALBERG is an Insider
Aimmune Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 14 2020
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 102,106 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 26 2016
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOMARIN PHARMACEUTICAL INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 3,300 shares
Current Value: $293,403
Latest Transaction: Jul 19 2016
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KATHRYN E FALBERG: Director
Holdings: 358,253 shares
Latest Transaction: May 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HUMAN GENOME SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Latest Transaction: May 31 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Latest Transaction: Sep 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nuvation Bio Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Latest Transaction: Feb 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 53,937 shares
Current Value: $699,563
Latest Transaction: May 16 2017
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trade Desk, Inc.
Industry: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
Position of KATHRYN E FALBERG: Director
Holdings: 22,641 shares
Current Value: $646,401
Latest Transaction: Nov 23 2020
$TTD Market Capitalization: $1.09B
$TTD Previous Close: $28.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tricida, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 42,760 shares
Latest Transaction: Jun 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UroGen Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Latest Transaction: Jun 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KATHRYN E FALBERG
Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 28.35 | 20,000 | 566,996 | 102,106 | 82.1 K to 102.1 K (+24.36 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | FALBERG KATHRYN E | Director | Option Exercise | A | 4.60 | 239,361 | 1,101,061 | 239,361 | |
| Nov 23 2020 | TTD | Trade Desk, Inc. | FALBERG KATHRYN E | Director | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
| Nov 23 2020 | TTD | Trade Desk, Inc. | FALBERG KATHRYN E | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 20,000 | |
| Nov 23 2020 | TTD | Trade Desk, Inc. | FALBERG KATHRYN E | Director | Option Exercise | M | 18.03 | 20,000 | 360,600 | 10,303 | |
| Nov 23 2020 | TTD | Trade Desk, Inc. | FALBERG KATHRYN E | Director | Sell | S | 822.00 | 629 | 517,038 | 2,641 | 3.3 K to 2.6 K (-19.24 %) |
| Nov 23 2020 | TTD | Trade Desk, Inc. | FALBERG KATHRYN E | Director | Sell | S | 820.00 | 13 | 10,660 | 3,270 | 3.3 K to 3.3 K (-0.40 %) |